Top 50 Life Science Startup Investors in Israel in May 2026

Portfolio highlights

• Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
• Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
• CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.

Portfolio highlights

• Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
• Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
• DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t

Portfolio highlights

• BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
• Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
• Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria

Portfolio highlights

• Teramount — Teramount changes the world of optical connectivity by offering a novel solution, the patented PhotonicPlug, for connecting optics to silicon.
• Onfire AI — Onfire is redefining revenue intelligence with vertical AI. The Onfire Platform combines data enrichment, intent signals, and agentic AI – designed specifically for B2B companies that sell software infrastructure. Onfire gathers intelligence on technical buyers from developer communities, GitHub history, and other non-traditional sources, creatinga one-of-its-kind database of accurate technographics and prospect-level intent signals. The Onfire Agent helps companies transform this data into high-impact prospecting, sales, and ABM.
• Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.

Portfolio highlights

• Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
• Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
• KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.

Portfolio highlights

• Nexite — Nexite develops a platform that provides item tracking, inventory transparency and business intelligence from manufacturing to the customer's home. Its miniature NanoBT batteryless tag can be read by any smartphone, costs a fraction of the cost of similar tags, and is small enough to embed into the item. The company was founded in 2017 andis headquartered in Tel Aviv, Israel.
• Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
• Adaptive6 — Cloud Cost Governance: Govern Cost Across Your Cloud and Code. Prevent and Remediate Waste. At Scale.

Portfolio highlights

• Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
• Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
• Sparrow Pharmaceuticals — Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.

Portfolio highlights

• Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
• Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
• Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Portfolio highlights

• NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
• iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
• The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

Portfolio highlights

• Spriggy — Spriggy is a mobile app with a linked prepaid card that helps kids learn the concept of digital money.
• Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
• August Robotics — August Robotics creates robots to automate "dirty, dangerous and dull" workflows across the B2B economy. The company's first robot, Lionel, automates the dull and labour intensive task of floor-marking for the global exhibition industry. Lionel has been used as a critical part of the trade show setup process by the world'slargest exhibition companies in Europe and USA. August Robotics' second robot, Diego, automates the dirty and dangerous task of disinfecting high-traffic public areas, such as hotels, offices and aged care centers, optimizing hygiene and reducing the risks of infection. The company is also working on a number of other robots, each leveraging August Robotics' industry leading proprietary mobile robotics platform, which enables August Robotics to generate new robots for new cases far more quickly and cheaply than other robotics companies. The physical world is ripe for disruption by robots, and August Robotics is leading the charge to do this in the B2B segment

Portfolio highlights

• KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
• March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
• Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.

Portfolio highlights

• iOrganBio — iOrganBio is a pioneering cell production platform that uses CellForge to facilitate the intelligent manufacturing of human cells and organoids.
• Kanary — Established in 2020 by U.S. campaign security and data science experts, Kanary finds, removes, and monitors your information across search engines, data brokers, and social media.
• Skynet Labs — ROYALTOGEL adalah situs paling ROYAL Bandar toto dengan hadiah promo toto / togel terbesar se Indonesia selain itu, juga terkenal dengan banyaknya pasaran toto terkenal seperti Singapore Pools, Hongkong Pools, Sydney Pools dan juga pasaran terkenal lainnya serta minimal deposit hanya butuh 10 ribu anda sudah bisa betting togel online dan juga live casino

Portfolio highlights

• iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
• Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.

Portfolio highlights

• The Good Feet Store — Go beyond insoles with arch supports designed to support your feet and help relieve foot, knee, hip, and back discomfort. Visit a store near you.
• Conditioned Air — Conditioned Air offers air conditioning contractor, AC and heating services for residential and commercial sectors.
• GLASS BOX TECHNOLOGY INC — Glass Box Technology Inc offers customizable network, storage, security, and server solutions designed to meet the needs of the industries.

Portfolio highlights

• EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible.
• Cyberwrite — AI-powered cyber insurance intelligence platform that transforms raw data into explainable, defensible financial decisions.
• GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Portfolio highlights

• Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
• Tenna Systems — Tenna Systems develops a platform that supports real-time monitoring, geolocation, and mitigation of radio-frequency interference to help maintain dependable connectivity for mission-critical systems. Its technology is informed by extensive experience in electromagnetic warfare and is designed to enhance awareness of RF activity across complexoperational environments. Tip&Cue supports defense, aerospace, and mobility organizations by enabling detection and analysis of interference sources and by strengthening the resilience of systems that depend on spectrum availability.
• Modulight Bio — Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders. The company’s technology uses optogenetics to modulate neuronal activity by targeting synaptic mechanisms. Its approach relies on endogenous cellular processes to adjust neural signaling with spatial and temporal precision. The platform is designedto address conditions associated with abnormal or excessive neuronal activation.

Portfolio highlights

• SOUS — One easy-to-use tool to grow traffic, make online sales, seamlessly handle orders and drive retention. Built for food entrepreneurs, built with taste.
• Tastewise — Tastewise is a consumer intelligence platform transforming food insights with AI. Discover trends, predict preferences, and drive innovation
• Rival Foods — We craft food we feel good about - Protein foods without compromises! At Rival Foods we create whole-cut specialties with remarkable texture, taste and juiciness, the ideal proposition for food professionals to create new plant-based eating experiences. Ready to use in all your favorite dishes! Interested in our products?

Portfolio highlights

• MixRift — MIXRIFT - game developers specialized in Mixed Reality
• unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
• Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Portfolio highlights

• Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
• Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
• ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Portfolio highlights

• Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
• Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
• Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.

Portfolio highlights

• Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
• Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
• Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.

Portfolio highlights

• Aromyx — Aromyx pioneers the creation of tastes and smells using a quantitative measurement system developed with biotechnology, data science, and AI.
• Brij — With one-touch, BRIJ allows consumers to gain product info, care instructions and discounts while you gain a deeper understanding of your consumer. Apps, paper manuals and hassles not required.
• BactoByte LTD — BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers.

Portfolio highlights

• Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
• smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
• TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.

Portfolio highlights

• NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
• Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
• Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.

Portfolio highlights

• PainTEQ — Explore PainTEQ's innovative solution for SI joint pain. Learn about the LinQ minimally invasive SI joint stabilization procedure, patient success stories, and our commitment to improving quality of life.
• TailorMed — Moving Mountains for Patients
• ClarVista Medical — ClarVista Medical is a developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing, ClarVista was spun out from Prospex Medical, a medical device incubator, to pursue the development of the HARMONI™ IOL. Between 2012 and 2014, the company developed the first generation HARMONI™system, conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system, conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.

Portfolio highlights

• NOVAMEAT — NOVAMEAT produces plant-based meat substitutes through advanced food printing and tissue engineering technologies. Join the #novameat movement.
• CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
• Braveheart Bio — Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions.

Portfolio highlights

• OneNotary — Looking for a reliable and convenient on-demand online notary service? OneNotary platform offers fully legal and secure notarization services in all 50 states.
• Foresee Genomics — Foresee Genomics brings high-precision NGS to every lab with fast, affordable diagnostics that advance personalized care and unlock growth.

Portfolio highlights

• Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
• Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
• Differential Bio — Differential Bio is integrating scale-down experiments with AI-based modeling to optimize how industry-relevant microbes grow ("biomass fermentation") and produce ("precision fermentation"). By optimizing bioprocesses and growth conditions, the company is not only increasing their clients' R&D efficiency but alsodramatically improving bioproduction outcomes such as yield, cost efficiency, and product quality.

Portfolio highlights

• ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
• Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
• Intuition Robotics — The AI care companion robot for older adults

Portfolio highlights

• AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
• Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
• Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.

Portfolio highlights

• Iantrek — Iantrek develops technology for minimally invasive microinvasive glaucoma surgery. It was founded in 2019 and is based in White Plains, New York.
• CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
• Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.

Portfolio highlights

• Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
• Cybord — Cybord develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process. Cybord scans each component prior to placement by integrating with electronic product manufacturing equipment, and deep learning algorithms rate each component based on Cybord’sglobal component database. Between 5 to 10% of all electronic components are considered counterfeit, responsible for up to 35% of RMAs. With Cybord, OEMs, EMSs, and distributors ensure their products are of high quality and free of hardware-cyber threats
• Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges

Portfolio highlights

• Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
• Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
• Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.

Portfolio highlights

• GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.

Portfolio highlights

• GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Portfolio highlights

• Akili Interactive Labs — Akili Interactive is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine.
• NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
• Scipio Bioscience — Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation solutionfor single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics.

Portfolio highlights

• Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
• Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
• Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.

Portfolio highlights

• SENCROP — Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making moreefficient and sustainable farming possible
• Source Defense — Source Defense provides an entirely new solution, leveraging a fully automated, machine-learning-assisted set of policies that ensure 3rd party JavaScript integrations operating on your website maximize user experience and eliminate the threat of such integrations being leveraged for malicious website activity.
• Pyramid Analytics — The Pyramid Decision Intelligence Platform is built to power faster and sharper decisions. Learn how it can improve your business decisions.

Portfolio highlights

• Ensoma — Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As aresult, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.
• Disc Medicine — Committed to turning scientific discoveries into effective medicines that will disrupt the current standard of care, alleviate suffering, and have a meaningful impact on the lives of patients and their families.
• Harpoon Therapeutics — Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, orantigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer.

Portfolio highlights

• Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
• Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
• Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.

Portfolio highlights

• ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
• KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
• Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.

Portfolio highlights

• CytoReason — CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases,reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
• AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
• EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

Portfolio highlights

• Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
• Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
• Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

Portfolio highlights

• BIOMx — BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators:Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.
• Mitoconix Bio — Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.Mitochondria generates ATP, the energy source for all cellular activities. Mitochondria are also involved in other essential cellular functions, including calcium sequestration, amino acid and lipid metabolism,keeping balanced redox potential and orchestrating programmed cell death. In neurons in particular, mitochondria are very dynamic organelles that constantly undergo fission (division) and fusion. This process, called mitochondrial dynamics, is critical in maintaining healthy and functional mitochondria under both normal conditions and in response to stress and in ensuring having viable mitochondria along the axons and in the synaptic boutons. A defect in either fusion or fission limits mitochondrial motility, decreases energy production, increases oxidative stress and activates pro-apoptotic signaling thereby promoting cell dysfunction and death.Mitoconix’ lead drug is a first-in-class inhibitor of pathological mitochondrial fragmentation and dysfunction with demonstrated in vivo efficacy in animal models of Huntington’s (HD) and Parkinson’s diseases (PD) and beneficial activity in patient-derived cells of HD, sporadic and genetic PD, and sporadic and genetic Alzheimer’s disease (AD).
• ImmPACT Bio — ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.

Portfolio highlights

• Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
• Voya Energy — Voya Energy is an energy management company that has developed technology to transform high-energy recycled metals into a safe fuel.
• StellarFi — We Pay Your Bills, So YouCan Build Credit. With Stellar your bills are paid on time and on your terms.

Portfolio highlights

• Vytal.ai — Vytal allows for brain health evaluation in minutes with just a laptop. Take control of your cognitive health.
• Akhetonics — Creating the first all-optical RISC Processor
• Greena World — In a world where travel connects us, we often overlook the impact we leave behind. Tourism accounts for over 8% of global CO2 emissions. Beyond environmental challenges like deforestation, pollution, and water scarcity, local communities also face pressure, experiencing changes in their traditions and ways of life.With expertise from SwanseaUniversity and the United Nations, our team recognised these challenges and envisioned a world where travel helps, not harms. Introducing Greena World. More than just a piece of technology, it's a guide for hotels and restaurants, helping them understand, improve, and share their impact on both the environment and local communities.The true beauty of embracing sustainability? The rewards. With the Greena Index, businesses can improve their sustainability and, in doing so, unlock a new market of over 100+ million eco-conscious travellers, boost revenues, and save on operating costs.The sustainable tourism sector is rapidly expanding, currently valued at $75B and witnessing a growth rate of 9.7% each year. While our initial focus is on hotels and restaurants, the Greena Index has ambitions to reshape the entire spectrum of the industry, from airlines to activities and destinations.Join us on a mission to transform the entire tourism industry for many generations to come.

Portfolio highlights

• Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
• Diptera — Developing technology to fight mosquitoes with mosquitoes.
• Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.

Portfolio highlights

• Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

Portfolio highlights

• Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
• Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
• DOT Compliance — Dot Compliance - Get life-changing products to market faster and safer with the industry's first AI-powered eQMS. Get a Demo.

Portfolio highlights

• LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
• Sqwik - powered by Geev.Me.Tech LTD — Sqwik is a new way to create, join & follow fun activities, with new friends, within 3 hours.
• Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant